News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Azopharma Product Development Group and ACCU-BREAK Pharmaceuticals, Inc. Announce Strategic Alliance Partnership



1/18/2008 9:17:47 AM

MIRAMAR & PLANTATION, Fla.--(BUSINESS WIRE)--Privately-held Azopharma Product Development Group, Inc. (“Azopharma”) and ACCU-BREAK Pharmaceuticals, Inc. (“ABP”) announced today the signing of a strategic alliance agreement in which Azopharma will become the “center of excellence” for developing products based on ABP’s innovative ACCU-BREAK™ patented tablet technologies which allow for accurate and individualized dosage adjustment.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES